Well now I just found out that it is not even AMRN presenting at the BofA conference but it is ARNA. Looks like I got my wires crossed and need to check on this info. This may all be related to ARNA and not to AMRN. I am thoroughly confused!! Can anyone confirm? TIA
Was just informed that the company is presenting at a BofA investment conference in the near term. This research has not been released yet. Perhaps waiting until after the conference to initiate coverage and release their thesis.
Recent developments regarding internal modifications to NCE determination within the FDA leads us to believe that AMRN will finally be awarded NCE status this Friday. Also, we believe that the company will be acquired shortly thereafter. Overweight with a $25 price target.
We expect Amarin will receive NCE status when the FDA updates the Orange Book next Friday. We believe that this will once again spark buy out negotiations with a deal taking place in the 25-28 dollar range.
We believe that Amarin will finally receive NCE status when the Orange Book is updated today. We also believe that this will be the catalyst to complete either a buy out of the company or secure a major partnership. Reiterate buy rating with a price target of 20 with the possibility of higher price targets.
He says that he has been taking vascepa for a month and has been commenting in its effects. I wonder if it has cleared up the bad breath, dandruff, herpes and genital warts lol. You guys should come over to ihub. You will see a bunch of familiar face lifts lol. Come on over its a hoot!!!
Basically says that after meeting with management yesterday they feel that the company wil get NCE when the OB is updated next week. They believe that this will be the catalyst to a sale of the company as many suitors have been waiting for the decision.
The new article says that azn will buy amrn for 4.2 bil(25 a share fully diluted) plus a cvr with future milestones. They are just waiting for nce to granted.They expect nce to be given when the orange book is updated this month.